Yew Bio Pharm Income Statement - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.26 $0 (0%) YEWB stock closing price Apr 28, 2017 (Closing)

Financial analysis of Yew Bio Pharm involves more than just checking the Yew Bio Pharm stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline and bottomline numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $14.67M to $12M and how operating and non operating activities have impacted the YEWB stock. The Yew Bio Pharm profit and loss statement for 2016-Q4 shows a profit of $-1.43M. Profits have reduced from $1.08M QoQ. Apart from this an investor should also check Yew Bio Pharm assets and Yew Bio Pharm free cash flow. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Yew Bio Pharm Net Sales or Revenues
12M14.67M16.06M8.62M17.27M5M4.67M2.64M1.9M1.7M
Cost Of Goods Sold (COGS)13.23M13.24M14.41M7.22M15.52M3.57M2.28M1.17M0.9M0.29M
Yew Bio Pharm Gross Profit
-1.23M1.41M1.64M1.39M1.78M1.41M2.37M1.47M1.01M1.4M
Research & Development Expense----------
Selling General & Admin Expense0.16M0.29M0.34M0.31M0.46M0.48M0.48M0.47M0.41M0.51M
Income Before Depreciation Depletion Amortization-1.38M1.11M1.3M1.07M1.32M0.93M1.89M0.99M0.61M0.89M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M-0.03M--0.02M0.05M-0.11M---
Interest Expense----------
Yew Bio Pharm Pretax Income
-1.41M1.08M1.3M1.05M1.38M0.93M2M0.99M0.61M0.89M
Provision for Income Taxes0.01M----0.04M--0.04M--
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M
Average Shares used to compute Diluted EPS51.88M51.89M51.88M51.88M51.88M52.19M57.62M58.23M--
Average Shares used to compute Basic EPS51.88M51.88M51.88M51.88M51.88M52.16M52.13M52.13M--
Income Before Nonrecurring Items-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M--
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
-0.030.020.030.020.030.020.040.02--
Yew Bio Pharm Earnings Per Share Diluted Net
-0.030.020.030.020.030.020.030.02--
EPS Diluted Before Nonrecurring Items-0.030.020.030.020.030.020.030.02--
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

It is very helpful to read a report on Yew Bio Pharm stock analysis. An investor must check the following items in an income statement:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that YEWB stock has a topline or revenue of $12M for 2016-Q4 as per this Yew Bio Pharm revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $12M - other expenses = $-1.43M for YEWB stock. An improving bottomline implies that the company is growing profits.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time. .